Relationship between hemostatic markers and platelet indices in patients with aortic aneurysm

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 6, 2006, Pages 451-456

  Ihara, Akihiro ^a,b,c   Matsumoto, Kengo ^a   Kawamoto, Toshiharu ^a   Shouno, Saburou ^a   Kawamoto, Jun ^a   Katayama, Akira ^a   Yoshitatsu, Masao ^a   Izutani, Hironori ^a  

^a National Hospital Organization   (Japan)

^b Kamo Psychiatry Medical Center   (Japan)

^c National Hospital Organization   (Japan)

Author keywords

Aortic aneurysm; Hemostatic molecular markers; Interleukin 6; Platelet index; Von Willebrand factor antigen

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIGEN; BIOLOGICAL MARKER; D DIMER; INTERLEUKIN 6; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR ANTIGEN;

ADULT; AGED; AORTA ANEURYSM; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; THROMBOGENESIS;

ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PROTEINS; CELL SIZE; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 34250203213     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000102053     Document Type: Article

References (20)

1. Thompson CB, Love DG, Quinn PG, Valeri CR: Platelet size does not correlate with platelet age. Blood 1983;62:487-494.
2. Levin J, Bessman JD: The inverse relationship between platelet volume and platelet number. J Lab Clin Med 1983;101:295-307.
3. Pizzulli L, Yang A, Martin JF, Luderitz B: Changes in platelet size and count in unstable angina compared to stable angina or noncardiac chest pain. Eur Heart J 1998;19:80-84.
4. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, Sunder-Plassmann R: Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;399-404.
5. Mathur A, Robinson MS, Cotton J, Martin JF, Erusalimsky JD: Platelet reactivity in acute coronary syndromes: evidence for differences in platelet behaviour between unstable angina and myocardial infarction. Thromb Haemost 2001;85:989-994.
6. Cay S, Biyikoglu F, Cihan G, Korkmaz S: Mean platelet volume in the patients with cardiac syndrome X. J Thromb Thrombolysis 2005;20:175-178.
7. Ihara A, Matsumoto K, Kawamoto T, Shouno S, Kawamoto J, Katayama A, Yoshitatsu M, Izutani H: Evaluation of platelet indexes in patients with aortic aneurysm. Pathophysiol Haemost Thromb 2005;34:269-273.
8. Balduini Cl, Salvini M, Montani N, Noris P, Sepedini P, Belleti S, Gamba G: Activation of the hemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. Haematologica 1997;82:581-583.
9. Lee AJ, Fowkes FG, Lowe GD, Rumley A: Haemostatic factors, atherosclerosis and risk of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 1996;7:695-701.
10. Koenig W, Rothenbacher D, Hoffmeister A, Griesshammer M, Brenner H: Plasma fibrin D-dimer levels and risk of stable coronary artery disease: results of a large case-control study. Arterioscler Thromb Vasc Biol 2001;21:1701-1705.
11. Blann AD, Devine C, Amiral J, McCollum CN: Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls. Blood Coagul Fibrinolysis 1996;7:695-701.
12. Adam DJ, Haggart PC, Ludlam CA, Bradbury AW: von Willebrand factor and platelet count in ruptured abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2003;26:412-417.
13. Nomura F, Ihara A, Yoshitatsu A, Tamura K, Katayama A, Ihara K: Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm. Eur J Cardiothorac Surg 2003;23:1034-1039.
14. Yamazumi K, Ojiro M, Okumura H, Aikou T: An activated state of blood coagulation and fibrinolysis in patents with abdominal aortic aneurysm. Am J Surg 1998;175:297-301.
15. Ihara A, Shiiki T, Sakaguti R, Kobayashi Y, Tokioka M, Imaizumi M, Yutani T, Tsushima M: Study of von Willebrand factor and antithrombin III in patients with atherosclerosis. Iryo 1988;42:168-172.
16. Jones KG, Brull DJ, Broun LC, Sian M, Greenhalph RM, Humphries SE, Powell JT: Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-2265.
17. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjala H, Airaksinen J, Leinonen M, Saikku P, Juvonen T: Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 1997;17:2843-2847.
18. von der Loo B, Martin JF: A role for changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol 1999;19:672-679.
19. Holmberg A, Bergqvist D, Siegbahn A: Coagulation and fibrinolysis after open infrarenal abdominal aortic aneurysm repair in a long-term perspective. Thromb Res 1999;96:99-105.
20. Adam DJ, Ludlam CA, Ruckley CV, Bradbury AW: Coagulation and fibrinolysis in patients undergoing operation for ruptured and nonruptured infrarenal abdominal aortic aneurysms. J Vasc Surg 1999;30:641-650.